Biological Dynamics develops next-generation diagnostics enabling early cancer detection and treatment monitoring. When cancer is detected in its early stages, using existing therapies, patients for most cancers have a greater than 95% survival rate. Biological Dynamics enables the early detection of cancer with its novel AC Electrokinetic microarray. This technology rapidly isolates, concentrates and detects cancer biomarkers from whole blood, plasma or serum, empowering physicians to detect cancer from a simple blood draw and rapidly intervene, increasing patient survivability while driving down the cost of care. Founded in 2008 by UCSD bioengineering students and faculty, Biological Dynamics closed its Series A fundraising in March of 2010.
www.biologicaldynamics.com











